Physician profile
Jonathan A Rogozinski
NPI 1699138909
$8,734.09
in general payments reported to CMS, 2019-2025
14 companies · $310 in 2025
The $310 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.99 · 2020: $63.45 · 2021: $101 · 2022: $2,798 · 2023: $2,692 · 2024: $2,703 · 2025: $310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,937 · Food and Beverage: $2,768.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,936.57 |
| Food and Beverage | $2,768.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,717.72 | 2022-2025 | T2 Alpha, Gamma, Inspace |
| Medtronic, INC. | $2,470.79 | 2022-2023 | Unid_pass, Infinity Occipitocervical Upper Thoracic System, Clydesdale Ptc Spinal System |
| Nuvasive, INC. | $1,696.96 | 2022-2023 | Xlif, Tlif, Simplify Cervical Artificial Disc |
| Orthofix Medical, INC. | $656.52 | 2023-2025 | 7d Surgical System, Northstar, Cervical-Stim |
| Depuy Synthes Sales INC. | $351.80 | 2023-2025 | Na, Tfn-Advance, Fibulink |
| Si-Bone, INC. | $343.93 | 2021-2023 | |
| Zimmer Biomet Holdings, INC. | $102.30 | 2022 | |
| Team 1, LLC | $68.16 | 2025 | |
| Mallinckrodt Enterprises LLC | $66.99 | 2019 | |
| Providence Medical Technology, INC. | $66.67 | 2022 | |
| Mallinckrodt Hospital Products INC. | $63.45 | 2020 | |
| Ebi, LLC | $51.93 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Highridge Medical LLC | $51.93 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Zimvie INC. | $24.94 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Rogozinski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.